2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Random Allocation: new trials by email Literature Review of Random Allocation trials Research Report on Random Allocation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301 CTx-1301-Dexmethylphenidate 12.5 mg (titration only), CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose), CTx-1301-Dexmethylphenidate 25mg (randomized fixed dose) - ADHD, Attention Deficit Hyperactivity Disorder | Phase 3 | Completed | Cingulate Therapeutics | 103 | 2023-08-01 | 2026-01-22 |
| Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison isoniazid , randomized, open label, rifampin, randomized, open label - Tuberculosis | Phase 3 | Completed | National Taiwan University Hospital | 2384 | 2008-01-01 | 2010-11-29 |
Attention Deficit Disorder with Hyperactivity (1) · Tuberculosis (1)
Cingulate Therapeutics (1) · National Taiwan University Hospital (1)
Taiwan (1) · United States (1)
Ann Childress, MD (1) · Li-Min Huang, MD, PHD (1) · Matt Brams, MD (1)